Yao Wang

I'll research this attorney before drafting.

Let me verify the tracked litigation and PTAB work.

Let me check additional PTAB appearances and bar/education corroboration.

Yao Wang — Patent Litigation Practice Summary

Focus areas. Dr. Yao Wang's practice at Fish & Richardson is centered on post-grant practice and patent prosecution rather than frontline trial work. The firm's bio describes his emphasis as post-grant proceedings, patent prosecution, client counseling, and portfolio development, with additional participation in U.S. district court cases and ITC proceedings. His technical background spans electrical engineering, computer science, biomedical engineering, and physics; his prosecution work covers semiconductor processing, integrated circuit design, communication networks, storage devices, database systems, computer vision, and medical imaging systems. The litigation in his tracked docket, the Nearmap/EagleView aerial-imagery dispute, fits that profile — software and image-processing subject matter (automated roof measurement from aerial photographs and geospatial databases).

Side preference. His four tracked appearances split evenly: two plaintiff-side and two defendant-side. In practice, however, all four trace to the same dispute and the same client, Nearmap — appearing for Nearmap as petitioner/plaintiff challenging EagleView's patents and for Nearmap as defendant in EagleView's Utah infringement suit (D. Utah No. 2:21-cv-00283). He is not an NPE/PAE-side specialist; he supports a single operating company on both sides of a two-front campaign. His tracked roles are supporting—back-up counsel (twice), additional counsel, and team member—not lead counsel, which is consistent with a post-grant/prosecution-anchored practice rather than a first-chair trial practice.

Firm context. He is a principal in the Washington, D.C. office of Fish & Richardson P.C., elevated to principal effective January 1, 2021. Sources reviewed show no prior law firm; before his legal career he was a senior member of the research staff at Philips Research North America and a senior scientist at Pfizer Global R&D. He is not in-house. He has been named a USPTO Patent Pro Bono Achievement Certificate recipient (2020) and recognized in Best Lawyers: Ones to Watch beginning in 2026.

Notable matters and PTAB/IPR experience. His most prominent tracked matter is Nearmap US, Inc. v. Eagle View Technologies, Inc. and the related PTAB proceedings. Reported outcomes in that campaign include the PTAB's unpatentability findings on EagleView's U.S. Patents 8,670,961 and 8,078,436, affirmed by the Federal Circuit in Eagle View Technologies, Inc. v. Nearmap US, Inc., No. 24-1488 (Fed. Cir. Feb. 3, 2026); a Director Review remand of the '737 patent IPR (IPR2022-00734) that led to a July 2024 unpatentability finding; and PTAB denials of institution on the '648 and '657 patents in October 2024. The district court case was stayed in August 2025 and the parties settled in May 2026. He appears in PTAB filings as back-up counsel (Reg. No. 61,757), including in IPR2022-00734 for Nearmap, and his firm bio notes a single PTAB oral argument. A PTAB mandatory notice in IPR2024-00934 (Texas Instruments v. ParkerVision) also lists him as back-up counsel for the petitioner. These are counsel-of-record listings; no source reviewed attributes a particular win or loss to his individual arguments.

Bar and education. J.D., George Washington University Law School (2012); Ph.D., Biomedical Engineering, University of Michigan (2002); M.S., Computer Science and Engineering, University of Michigan (2002); M.S., Imaging Physics, University of Toronto (1998); B.S., Electrical Engineering, Nanjing University (1995). Registered to practice before the USPTO (Reg. No. 61,757); a state bar admission was not confirmed in the sources reviewed.

Note: A different Fish & Richardson attorney, Yong Wang (California), appears in unrelated matters such as Omnitracs v. Platform Science; the entries above are tied to Yao Wang, Reg. No. 61,757, D.C. office.